Chemoinformaics analysis of 9,16-Dihydroxyhexadecanoic acid
Molecular Weight | 288.428 | nRot | 15 |
Heavy Atom Molecular Weight | 256.172 | nRig | 11 |
Exact Molecular Weight | 288.23 | nRing | 0 |
Solubility: LogS | -3.232 | nHRing | 0 |
Solubility: LogP | 4.055 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 51.2654 |
nHD | 3 | BPOL | 32.9706 |
QED | 0.663 |
Synth | 3.788 |
Natural Product Likeliness | 2.528 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.057 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.489 |
MDCK | 0.0000145 |
BBB | 0.758 |
PPB | 0.942229 |
VDSS | 2.06 |
FU | 0.0324427 |
CYP1A2-inh | 0.073 |
CYP1A2-sub | 0.554 |
CYP2c19-inh | 0.128 |
CYP2c19-sub | 0.928 |
CYP2c9-inh | 0.132 |
CYP2c9-sub | 0.56 |
CYP2d6-inh | 0.026 |
CYP2d6-sub | 0.193 |
CYP3a4-inh | 0.11 |
CYP3a4-sub | 0.285 |
CL | 9.095 |
T12 | 0.162 |
hERG | 0.007 |
Ames | 0.004 |
ROA | 0.022 |
SkinSen | 0.061 |
Carcinogencity | 0.073 |
EI | 0.881 |
Respiratory | 0.499 |
NR-Aromatase | 0.096 |
Antiviral | Yes |
Prediction | 0.662659 |